Preparation and characterization of alginate/chitosan formulations for ciprofloxacin-controlled delivery

被引:34
作者
Kyziol, Agnieszka [1 ]
Mazgala, Aleksandra [1 ]
Michna, Justyna [1 ]
Regiel-Futyra, Anna [1 ]
Sebastian, Victor [2 ,3 ]
机构
[1] Jagiellonian Univ, Fac Chem, Krakow, Ingardena, Poland
[2] Nanosci Inst Aragon INA, Dept Chem Engn, Zaragoza, Spain
[3] CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Zaragoza, Spain
关键词
Chitosan; alginate; ciprofloxacin; controlled release; CORE-SHELL NANOPARTICLES; CHITOSAN NANOPARTICLES; CONTROLLED-RELEASE; IN-VITRO; ALGINATE NANOPARTICLES; ORAL DELIVERY; DRUG-RELEASE; MICROSPHERES; SYSTEMS; DERIVATIVES;
D O I
10.1177/0885328217714352
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this work, alginate beads loaded with ciprofloxacin (AL_CP) and alginate beads loaded with ciprofloxacin and covered by chitosan (AL_CP_CS) were prepared by emulsification technique in combination with internal gelation method. Physicochemical characterization of the resulting formulations revealed the hydrodynamic diameter and Zeta potential ca. 160 nm and ca. -32 mV in the case of AL_CP and ca. 240 nm and ca. +14 mV in the case of AL_CP_CS (pH = 6.0), respectively. Kinetics of ciprofloxacin release from alginate/chitosan formulations was studied in different media (pH = 1.2, 6.8, and 7.4). Covering alginate core with a polycation such as chitosan moderates the drug release, resulting in a pH-sensitive hybrid controlled-release system. Herein, alginate beads with encapsulated ciprofloxacin covered with chitosan are proposed as an effective oral delivery system since the drug release from alginate core is limited in low pH solution (gastric conditions).
引用
收藏
页码:162 / 174
页数:13
相关论文
共 65 条
  • [1] Freeze-drying of nanoparticles: Formulation, process and storage considerations
    Abdelwahed, Wassim
    Degobert, Ghania
    Stainmesse, Serge
    Fessi, Hatem
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) : 1688 - 1713
  • [2] Chitosan-alginate multilayer beads for controlled release of ampicillin
    Anal, AK
    Stevens, WF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 290 (1-2) : 45 - 54
  • [3] Aspe M., 2012, J EXP MICROBIOL IMMU, V16, P42
  • [4] Azizi E, 2010, INT J NANOMED, V5, P455
  • [5] Determination of pKa values of active pharmaceutical ingredients
    Babic, Sandra
    Horvat, Alka J. M.
    Pavlovic, Dragana Mutavdzic
    Kastelan-Macan, Marija
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2007, 26 (11) : 1043 - 1061
  • [6] Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment
    Bagre, Archana Pataskar
    Jain, Keerti
    Jain, Narendra K.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 456 (01) : 31 - 40
  • [7] Microfluidic Directed Synthesis of Alginate Nanogels with Tunable Pore Size for Efficient Protein Delivery
    Bazban-Shotorbani, Salime
    Dashtimoghadam, Erfan
    Karkhaneh, Akbar
    Hasani-Sadrabadi, Mohammad Mahdi
    Jacob, Karl I.
    [J]. LANGMUIR, 2016, 32 (19) : 4996 - 5003
  • [8] Alginate-based nanofibrous scaffolds: Structural, mechanical, and biological properties
    Bhattarai, Narayan
    Li, Zhensheng
    Edmondson, Dennis
    Zhang, Miqin
    [J]. ADVANCED MATERIALS, 2006, 18 (11) : 1463 - +
  • [9] Preparation of coated nanoparticles for a new mucosal vaccine delivery system
    Borges, O
    Borchard, G
    Verhoef, JC
    de Sousa, A
    Junginger, HE
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 299 (1-2) : 155 - 166
  • [10] Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination
    Borges, Olga
    Cordeiro-da-Silva, Anabela
    Romeijn, Stefan G.
    Amidi, Maryam
    de Sousa, Adriano
    Borchard, Gerrit
    Junginger, Hans E.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 114 (03) : 348 - 358